Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Oslo
- City of Hope
- Center for Drug Evaluation and Research (CDER)
- Johns Hopkins University
- Nanyang Technological University
- Zintellect
- Amgen
- Australian Academy of Science Research Funding
- Florida Atlantic University
- KU LEUVEN
- National University of Singapore
- Nature Careers
- Northeastern University
- Paul Scherrer Institut Villigen
- The University of Edinburgh;
- Umeå universitet stipendiemodul
- University of Bergen
- University of British Columbia
- University of California Los Angeles
- University of Michigan
- University of North Carolina at Chapel Hill
- University of North Carolina at Charlotte
- 12 more »
- « less
-
Field
-
the ADAPT platform, a novel technology that converts antibody CDR-H3 loops into β-hairpin peptide mimetics with antibody-like specificity and improved pharmacokinetic properties. The primary biological focus
-
this. Lets change the world. Responsibilities: Develop novel and biopharmaceutical industry leading peptide, protein, antibody and multispecific antibody MS and MS/MS analytical techniques, automation sample
-
samples Generation of recombinant monoclonal antibodies Generation of BCR-transduced cells lines Antibody-antigen binding studies Targeting of B cells in in vitro assays Writing of scientific papers and
-
de Alwis’s team is searching for a passionate Research Fellow to join her team for an infectious disease antibody adventure. Her team works on different aspects of antibody and B cells responses
-
therapeutics (eg. oncolytic viruses, antibody drug conjugates and T-cell engagers) Lab duties, including but not limited to: cell culture, viral transduction, western blotting, qPCR, immunofluorescence and
-
capabilities for cell therapy (CAR-T cells, stem cells, etc.), monoclonal antibodies, and small molecule generation, in line with our vested interest in commercializing our discoveries so that they can reach
-
, antibody formation and tolerance and vaccine research Closing date: 1 June 2025 Closed Career Award Haddon Forrester King Medal, sponsored by Rio Tinto Recognises original and sustained contributions
-
: · Contribute to the development of CD38 antibody‑drug conjugates (ADCs) and other multiple myeloma targets, including monoclonal antibody (mAb) engineering, ADC conjugation, biophysical characterization (SPR
-
to develop new vaccine candidates for various veterinary viruses, and antibody and protein purification is an important part of vaccine development. Several successful vaccine candidates have been created and
-
? No Offer Description The downstream purification of biomolecules (e.g., monoclonal antibodies) is an indispensable part of biopharmaceutical production of therapeutics such as therapeutics